AI-Based Clinical Trial Solution Providers Market Growth, Trends Report, Size, Share 2024 To 2033

The ai-based clinical trial solution providers market size has grown exponentially in recent years. It will grow from $2 billion in 2023 to $2.47 billion in 2024 at a compound annual growth rate (CAGR) of 23.7%. The growth in the historic period can be attributed to increased complexity in clinical trials, growing volume of clinical trial data, regulatory compliance challenges, drug discovery and development demands, personalized medicine trends.

The ai-based clinical trial solution providers market size is expected to see exponential growth in the next few years. It will grow to $5.65 billion in 2028 at a compound annual growth rate (CAGR) of 23.0%. The growth in the forecast period can be attributed to integration with real-world evidence (rwe), advancements in natural language processing (nlp), decentralized clinical trials adoption, expansion of therapeutic areas, enhanced predictive analytics. Major trends in the forecast period include collaboration with biotech and pharma companies, patient-centric approaches, predictive analytics for trial design, real-world evidence integration, blockchain for data security.

Market Overview -
AI-based clinical trial solution providers are companies or organizations that offer technological solutions leveraging artificial intelligence (AI) for various aspects of the clinical trial process in the healthcare and pharmaceutical industries. These solutions aim to enhance clinical trials' efficiency, accuracy, and overall effectiveness, from study design and patient recruitment to data analysis and regulatory compliance.

Download Free Sample of Report -

https://www.thebusinessresearchcompany.com/sample.aspx?id=13575&type=smp

Accelerated Growth in AI-Based Clinical Trial Solutions Market Driven by Rising Adoption of AI Technology

The increasing adoption of AI technology is expected to propel the growth of the AI-based clinical trial solution provider market going forward. Artificial intelligence (AI) refers to the development of computer systems or software that can perform tasks that typically require human intelligence. AI technology is being increasingly used by clinical trial solution providers to bring efficiency, accuracy, and innovation to various stages of the clinical trial lifecycle, ultimately contributing to improved patient outcomes and advancements in medical research. For instance, in May 2022, according to The International Business Machines Corporation (IBM), a US-based technology corporation, the adoption rate of AI globally increased significantly by 35%, up four points from the previous year. Further, in 2022, 13% more firms are projected to have used AI than in 2021, and around 35% of organizations reported adopting AI in their company, 42% are considering AI for adoption, and two-thirds of the companies (66%) are either presently executing or intending to utilize AI to meet their sustainability goals. Therefore, the increasing adoption of AI technology is driving the growth of the AI-based clinical trial solution provider market.

Competitive Landscape -
Major companies operating in the ai-based clinical trial solution providers market report are International Business Machines Corporation, AstraZeneca, Takeda Pharmaceutical Company Limited, IQVIA Holdings Inc., BenevolentAI, Charles River Laboratories, Flatiron Health, Saama Technologies Inc., CytoReason, Median Technologies SAS, Concentro Health AI. , AiCure, LLC, DEEP LENS AI Inc., GNS Healthcare, Inc., Ardigen, Koneksa Health Inc., Unlearn.AI Inc., PathAI Inc., Deep 6 AI Inc., Intelligencia Inc., Exscientia, Prometheus Biosciences, Inc., Renalytix AI plc, BioAge Labs Inc., Mendel Health Inc

Innovative AI-Driven Data Platforms Transforming Clinical Trials

Major companies operating in the AI-based clinical trial solution providers market are developing innovative technological innovations in the market, such as the Saama AI-driven data platform, to accelerate clinical development and strengthen their position in the market. An AI-driven data platform is a software solution that leverages artificial intelligence (AI) and machine learning (ML) to automate and enhance various data management and analysis processes. For instance, In June 2023, Saama Technologies, Inc., a US-based software company, introduced an AI-driven data platform called Saama. An AI-driven data platform streamlines clinical trial processes by centralizing and standardizing data, offering real-time insights into trial operations, financials, and patient data. The platform utilizes AI and advanced analytics to automate tasks, enhance productivity, and provide deep insights into patient behaviors. With SaaS solutions like data hubs, operational insights, patient insights, S2S, and SDQ, Saama empowers AI-based clinical trial solution providers to optimize efficiency, accuracy, and effectiveness. Additionally, it aims to eliminate manual, resource-intensive activities and make clinical trials more efficient and effective.

Browse Full Report @

https://www.thebusinessresearchcompany.com/report/ai-based-clinical-trial-solution-providers-global-market-report

Key Segments -

The ai-based clinical trial solution providers market covered in this report is segmented -

1) By Clinical Trial Phase: Phase-I, Phase-II, Phase-III
2) By Therapeutic Application: Oncology, Cardiovascular Diseases, Neurological Diseases or Conditions, Metabolic Diseases, Infectious Diseases, Other Therapeutic Applications
3) By End-user : Pharmaceutical Companies, Academia, Other End-users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.